Главная
Study mode:
on
1
Introduction
2
Presentation
3
Monocle Antibody
4
How would we use it
5
Animal models
6
Neutralization data
7
Monoclonal antibodies
8
Vaccine response
9
Licensing strategy
10
Is the epitope normally exposed
11
Is the epitope conserved
12
The lead candidate
13
Indications
14
Who should get the vaccine
15
Antihuman antibody
16
Final comments
17
Outro
Description:
Explore the latest developments in universal influenza vaccine research presented at ICAAC 2012 in this 32-minute conference talk. Delve into the limitations of current strain-specific vaccines and the pressing need for a universal solution that can protect against any potential influenza strain. Learn about ongoing efforts and recent breakthroughs from experts Donna Ambrosino and Zachary Shriver of Visterra. Gain insights into monocle antibodies, animal models, neutralization data, and vaccine responses. Understand the licensing strategy, epitope conservation, and potential indications for a universal vaccine. Discover who might benefit from such a vaccine and the implications of antihuman antibodies in this comprehensive update on the quest for the "holy grail" of public health.

Universal Influenza Vaccine Update

American Society for Microbiology
Add to list